Disease-inducible transgene expression from a recombinant adeno- associated virus vector in a rat arthritis model

Journal of Virology

Volumn 73, Issue 4, 1999, Pages 3410-3417

  Pan, Ru Yu ^a   Xiao, Xiao ^b   Chen, Show Li ^a   Li, Juan ^b   Lin, Leou Chyr ^a   Wang, Hsian Jenn ^a   Tsao, Yeou Ping ^a,c  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR;

ADENO ASSOCIATED VIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; INFLAMMATION; INTRAARTICULAR DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; RHEUMATOID ARTHRITIS; TRANSGENE;

EID: 0033015013     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.4.3410-3417.1999     Document Type: Article

References (46)

1. Afione, S. A., C. K. Conrad, W. G. Kearns, S. Chunduru, R. Adams, T. Reynolds, W. B. Guggino, G. R. Cutting, B. J. Carter, and T. R Flotte. 1996. In vivo model of adeno-associated virus vector persistence and rescue. J. Virol. 70:3235-3241.
2. Arend, W. P., and J. M. Dayer. 1995. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis. Arthritis Rheum. 38:151-160.
3. Bakker, A. C., L. A. Joosten, O. J. Arntz, M. M. Helsen, A. M. Bendele, F. A. van de Loo, and W. B. van den Berg. 1997. Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human interleukin-1 receptor antagonist protein in the knee. Arthritis Rheum. 40: 893-900.
4. Bandars, G., P. D. Robbins, H. I. Georgescu, G. M. Mueller, J. C. Glorioso, and C. H. Evans. 1992. Gene transfer to synoviocytes: prospects for gene treatment of arthritis. DNA Cell Biol. 11:27-231.
5. Bandara, G., G. M. Mueller, M. H. Galea-Laure, M. H. Tindal, H. I. Georgescu, M. K. Suchanek, G. L. Hung, J. C. Glorioso, P. D. Robbins, and C. H. Evans. 1993. Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer. Proc. Natl. Acad. Sci. USA 90:10764-10768.
6. Beg, A. A., T. S. Finco, P. V. Natermet, and A. S. Baldwin. 1993. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation. Mol. Cell. Biol. 13:3301-3310.
7. Beutler, B., I. W. Milsark, and A. C. Cerami. 1985. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229:869-871.
8. Braude, A. I., J. L. Jones, and H. Douglas. 1963. The behavior of Escherichia coli endotoxin (Somatic antigen) during infectious arthritis. J. Immunol. 90:297-311.
9. Dayer, J. M., and H. Fenner. 1992. The role of cytokines and their inhibitors in arthritis. Ballieres Clin. Rheumatol. 6:485-516.
10. Ding, A. H., C. F. Nathan, and D. J. Stuehr. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol. 141:2407-2412.
11. Esser, R. E., S. A. Stimpson, W. J. Cromartie, and J. H. Schwab. 1985. Reactivation of streptococcal cell wall-induced arthritis by homologous and heterologous cell wall polymers. Arthritis Rheum. 28:1402-1411.
12. Esser, R. E., S. K. Anderle, C. Chetty, S. A. Stimpson, W. J. Cromartie, and J. H. Schwab. 1986. Comparison of inflammatory reactions induced by intraarticular injections of bacterial cell wall polymers. Am. J. Pathol. 122:323-334.
13. Evans, C. H., and P. D. Robbins. 1995. Possible orthopaedic applications of gene therapy. J. Bone Joint Surg. Am. 77:1103-1114.
14. Ferrari, F. K., T. Samulski, T. Shenk, and R. J. Samulski. 1996. Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J. Virol. 70:3227-3234.
15. Flotte, T. R., S. A. Afione, C. Conrad, S. A. McGrath, R. Solow, H. Oka, P. L. Zeitlin, W. B. Guggino, and B. J. Carter. 1993. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc. Natl. Acad. Sci. USA 90:10613-10617.
16. Flotte, T. R., X. Barraza-Ortiz, R. Solow, S. A. Afinoe, B. J. Carter, and W. B. Guggino. 1995. An improved system for packaging recombinant adeno-associated virus vectors capable of in vivo transduction. Gene Ther. 2:29-37.
17. Ghivizzani, S. C., E. R. Lechman, R. Kang, C. Tio, J. Kolls, C. H. Evans, and P. D. Robbins. 1998. Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor α soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects. Proc. Natl. Acad. Sci. USA 95:4613-4618.
18. Goldenburg, D. L., J. I. Reed, and P. A. Rice. 1984. Arthritis in rabbits induced by killed Neisseria gonorrhoeas and gonococcal lipopolysaccharide. J. Rheumatol. 11:3-8.
19. Guo, Z. S., L. H. Wang, R. C. Eisensmith, and C. L. Woo. 1996. Evaluation of promoter strength for hepatic gene expression in vivo following adenovirus-mediated gene transfer. Gene Ther. 3:802-810.
20. Henderson, B., R. C. Thompson, W. Hardingham, and J. Lewthwaite. 1991. Inhibition of interleukin-1 induced synovitis and articular cartilage proteoglycan loss in the rabbit knee by recombinant human interleukin-1-receptor antagonist. Cytokine 3:246-249.
21. Henkel, T., T. Machleidt, I. Alkalay, M. Kronke, Y. Ben-Neriah, and P. A. Baeuerle. 1993. Rapid proteolysis of 1 kappa B-alpha is necessary for activation of transcription factor NF-kappa B. Nature 365:182-185.
22. Hollingsworth, J. W., and E. Atkins. 1965. Synovial inflammatory response to bacterial endotoxin. Yale J. Biol. Med. 38:241-256.
23. Hung, G. L., J. Galea-lauri, G. M. Mueller, H. I. Georgescu, L. A. Larkin, M. K. Suchanek, M. H. Tindal, P. D. Robbins, and C. H. Evans. 1994. Suppression of intraarticular responses to interleukin-1 by transfer of the interleukin-1 receptor antagonist gene to synovium. Gene Ther. 1:64-69.
24. Kaklamanis, P. M. 1992. Experimental animal models resembling rheumatoid arthritis. Clin. Rheumatol. 11:41-47.
25. Le, C. H., A. G. Nicolson, A. Morales, and K. L. Sewell. 1997. Suppression of collagen-induced arthritis through adenovirus-mediated transfer of a modified tumor necrosis factor alpha receptor gene. Arthritis Rheum. 40:1662-1669.
26. Loser, P., G. S. Jennings, M. Strauss, and V. Sandig. 1998. Reactivation of the previously silenced cytomegalovirus major immediate-early promoter in the mouse liver: involvement of NFκB. J. Virol. 72:180-190.
27. Mohler, K. M., D. S. Torranceet, C. A. Smith, R. G. Goodwin, K. E. Stremler, V. P. Fung, H. Madani, and M. B. Widmer. 1993. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J. Immunol. 151:1548-1561.
28. Morrison, D. C., and J. Ryan. 1987. Endotoxins and disease mechanisms. Annu. Rev. Med. 38:417-432.
29. Muzyczka, N. 1992. Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr. Top. Microbiol. Immunol. 158:97-129.
30. Nita, I., S. C. Ghivizzani, J. Galea-Lauri, G. Bandara, H. I. Georgescu, P. D. Robbins, and C. H. Evans. 1996. Direct gene delivery to synovium. An evaluation of potential vectors in vitro and in vivo. Arthritis Rheum. 39:820-828.
31. Otani, K., I. Nita, W. Macaulay, H. I. Georgescu, P. D. Robbins, and C. H. Evans. 1996. Suppression of antigen-induced arthritis in rabbits by ex vivo gene therapy. J. Immunol. 156:3558-3562.
32. Palombella, V. J., O. J. Rando, A. L. Goldberg, and T. Maniatis. 1994. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell 78:773-785.
33. Prosch, S., K. Staak, J. Stein, C. Liebenthal, T. Stamminger, H.-D. Volk, and D. H. Kruger. 1995. Stimulation of the human cytomegalovirus IE enhancer/ promoter in HL-60 cells by TNFα is mediated via induction of NF-κB. Virology 208:197-206.
34. Remmers, E. F., R. Lafyatis, G. K. Kumkumaian, J. P. Case, A. B. Roberts, M. B. Sporn, and R. L. Wilder. 1990. Cytokines and growth regulation of synoviocytes from patients with rheumatoid arthritis and rats with streptococcal cell wall arthritis. Growth Factors 2:179-188.
35. Roessler, B. J., E. D. Allen, J. M. Wilson, J. W. Hartman, and B. L. Davidson. 1993. Adenoviral-mediated gene transfer to rabbit synovium in vivo. J. Clin. Invest. 92:1085-1092.
36. Russell, D. W., A. D. Miller, and I. E. Alexander. 1994. Adeno-associated virus vectors preferentially transduce cells in S phase. Proc. Natl. Acad. Sci. USA 91:8915-8919.
37. Sawchuk, S. J., G. Boivin, L. Duwel, W. Ball, K. Bove, B. Trapnell, and R. Hirsch. 1996. Anti-T cell receptor monoclonal antibody prolongs transgene expression on following adenovirus-mediated in vivo gene transfer. Hum. Gene Ther. 7:499-506.
38. Smith, R. J., J. E. Chin, L. M. Sam, and J. M. Justen. 1991. Biological effects of an interleukin-1 receptor antagonist protein on interleukin-1 stimulated cartilage erosion and chondrocyte responsiveness. Arthritis Rheum. 34:78-83.
39. Stimpson, S. A., R. E. Esser, P. B. Carter, R. B. Sartor, W. J. Cromartie, and J. H. Schwab. 1988. Lipopolysaccharide induces recurrence of arthritis in rat joints previously injured by peptidoglycan-polysaccharide. J. Exp. Med. 165: 1688-1702.
40. Sullivan, R., and C. W, Lo. 1997. Histochemical and fluorochrome-based detection of β-galactosidase, p. 229-246. In R. S. Tuan (ed), Recombinant protein protocols: detection and isolation. Humana Press, Totowa, NJ.
41. Thompson, J. E., R. J. Philips, H. Erdjument-Bromage, P. Tempst, and S. Ghosh. 1995. I kappa B-beta regulates the persistent response in a biphasic activation of NF-kappa B. Cell 80:573-582.
42. Xiao, X., J. Li, and R. J. Samulski. 1996. Efficient long-term transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol. 70:8098-8108.
43. Xiao, X., J. Li, T. J. McCown, and R. J. Samulski. 1997. Gene transfer by adeno-associated virus vectors into the central nervous system. Exp. Neurol. 144:113-124.
44. Xiao, X., J. Li, and R. J. Samulski. 1998 Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J. Virol. 72:2224-2232.
45. Yang, Y., H. C. Ertl, and J. M. Wilson. 1994. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenovirus. Immunity 1:433-442.
46. Yang, Y., F. A. Nunes, K. Berencsi, E. E. Furth, E. Gonczol, and J. M. Wilson. 1994. Cellular immunity to viral antigens limits E1-deleted adeno-viruses for gene therapy. Proc. Natl. Acad. Sci. USA 91:4407-4411.